The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and clinical research organization.
Rivanna's Accuro Shows Statistically Significant Efficacy And Safety For Combined Spinal- Epidural Anesthesia
Rivanna®, developers of world-first imaging-based medical solutions, today announced the results of a recent randomized controlled trial.
Ireland’s Kerry Group has added to its stable of probiotics with a deal announced today with VA-based biotech firm BIO-CAT Microbials, LLC.
Case Western Reserve University and Atelerix Life Sciences Inc. have signed a two-year option to license a novel family of small molecules to prevent or reverse life-threatening opioid-related side effects.
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
HemoShear Therapeutics, Inc. has identified a second drug target for the treatment of gout under its collaboration with Horizon Therapeutics plc.